相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Derivation and Validation of a Clostridium difficile Infection Recurrence Prediction Rule in a National Cohort of Veterans
Kelly R. Reveles et al.
PHARMACOTHERAPY (2018)
Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C-difficile infection
Z. Kassam et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
The effect of statins on the outcome of Clostridium difficile infection in hospitalized patients
A. Atamna et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection
Vijay C. Antharam et al.
PLOS ONE (2016)
Regional and seasonal variation in Clostridium difficile infections among hospitalized patients in the United States, 2001-2010
Jacqueline R. Argamany et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2015)
Recurrent Clostridium difficile infection: From colonization to cure
Kelsey Shields et al.
ANAEROBE (2015)
Clostridium difficile Infection
Daniel A. Leffler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Statins use and risk of mortality in patient with Clostridium difficile infection
W. Saliba et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Multistate Point- Prevalence Survey of Health Care- Associated Infections
Shelley S. Magill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The effects of statins on the clinical outcomes of Clostridium difficile infection in hospitalised patients
S. W. Park et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Markers of Intestinal Inflammation, Not Bacterial Burden, Correlate With Clinical Outcomes in Clostridium difficile Infection
Rana E. El Feghaly et al.
CLINICAL INFECTIOUS DISEASES (2013)
Can we identify patients at high risk of recurrent Clostridium difficile infection?
C. P. Kelly
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Statins in the critically ill
Isabelle De Loecker et al.
ANNALS OF INTENSIVE CARE (2012)
Recurrence Rate of Clostridium difficile Infection in Hospitalized Pediatric Patients with Inflammatory Bowel Disease
Judith R. Kelsen et al.
INFLAMMATORY BOWEL DISEASES (2011)
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
Chao-Yung Wang et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function
Thomas Jank et al.
GLYCOBIOLOGY (2007)
Cholesterol-dependent pore formation of Clostridium difficile toxin A
T Giesemann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Clostridium difficile toxins:: Mechanism of action and role in disease
DE Voth et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Clinically relevant differences between the statins: Implications for therapeutic selection
PH Chong et al.
AMERICAN JOURNAL OF MEDICINE (2001)
分享论文
